Aplastic Anemia And Myelodysplastic Syndromes International Foundation

Organizations:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Contact details for the Aplastic Anemia And Myelodysplastic Syndromes International Foundation address phone fax & website

Logo of the Aplastic Anemia And Myelodysplastic Syndromes International Foundation

Name: Aplastic Anemia And Myelodysplastic Syndromes International Foundation
  (AA&MDSIF)
Address: PO Box 310
  Churchton
  Maryland 20733
  United States
Telephone: 410 867 0242
  800 747 2820 Toll Free
Fax: 410 867 0240
Website: www.aamds.org

About The Aplastic Anemia And Myelodysplastic Syndromes International Foundation - AA&MDSIF

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is an independent non profit organization.

Founded in 1983 by patients, families and doctors, the AA&MDSIF mission is to support patients, families, and caregivers coping with Aplastic Anemia (AA), Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH), and related bone marrow failure diseases.

The Aplastic Anemia & MDS International Foundation:

What is aplastic anemia?

Aplastic anemia occurs when bone marrow stops making enough blood forming stem cells. In all three blood lines; red blood cells, white blood cells and platelets, patients with aplastic anemia have a low blood count. The bone marrow is found to be aplastic which means there is a low growth of blood forming stem cells.

Symptoms of aplastic anemia include:

Aplastic anemia treatments

Treatments vary on a case by case basis. Age is often the determining factor for which treatment to use. Stem cell transplantation may be used for individuals younger than 30 years and who have a matched sibling donor . Stem cell transplantation is a procedure which replaces defective bone marrow with healthy cells. Around 80% of patients make a complete recovery using stem cell transplantation.

For older patients with aplastic anemia, immune suppressing therapy with anti-thymocyte globulin(ATG) and cyclosporin is typically used. Around 70-80% of aplastic anemia patients respond to this treatment.

Organizations:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 

Organizations

Awareness Events Online Tools Conditions Software Organizations
Google